Clinical Trial Update: Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update on Rituximab for Non-Hodgkin's lymphoma or Hodgkin's disease; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Disease
• Non-hodgkin Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lymphoma | Phase 2 | Status: COMPLETED